eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0019158|hepatitis |
| Sentences | 11 |
| PubMedID- 25553983 | The association of nafld with chronic hepatitis c (chc) has been extensively studied but little is known about its coexistence with chronic hepatitis b (chb). |
| PubMedID- 22980664 | [expression of mcp-1 in the patients of chronic hepatitis b complicated with nonalcoholic fatty liver disease]. |
| PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
| PubMedID- 22989301 | Background and aim: non-alcoholic fatty liver disease (nafld) overlapping with chronic hepatitis b virus (hbv) infection is undergoing a rapid increase in china. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
| PubMedID- 26078820 | Related to this, nafld in hepatitis c virus patients is associated with oxidative damage, likely due to imbalances in trace metals [74]. |
| PubMedID- 24783906 | Existing dogma posits that liver biopsy is the most reliable approach for identifying the presence of steato- hepatitis and fibrosis in patients with nafld, but it is generally acknowledged that biopsy is limited by cost, sampling error, and procedure-related morbidity and mortality. |
| PubMedID- 26441244 | In addition to alcoholic induced hepatitis, the importance of non-alcoholic fatty liver disease (nafld) has progressively been emphasized in recent decades worldwide. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 25801076 | Background: the pnpla3/adiponutrin rs738409 c/g single nucleotide polymorphism is associated with the severity of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease, as well as the severity of steatosis and fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
Page: 1